Electronic Informed Consent for Biobanks - Webinar CD/Transcript

Quantity Discounts
1 - 2
3 - 4
5 - 6
7 - 9
10 - 9999

Electronic Informed Consent for Biobanks: Transitioning to a 21st-Century System

Many biobanks are still using a cumbersome paper-based system for documenting consent.

Join Susan G. Brink, DrPH — executive vice president of e-consent products and services at Enforme Interactive, Inc — for a 90-minute session discussing the implementation of e-Consent for biobanks. She will:

  • Provide guidelines for a flexible approach to collect and maintain patient consents.
  • Give examples of how an e-consent platform can address biobank issues including general consent for all uses, specific consent, specimen withdrawal by patient, specimen matching to consent and patient notification while maintaining confidentiality of patient information.
  • Provide a workflow analysis for a specimen management system with real time access to consent.

Order your copy today and discover how moving to an e-Consent system can simplify everything.

  • Auditors
  • Clinical project specialists
  • Clinical research associates
  • Clinical operations
  • Compliance officers
  • Consultants/service providers
  • Engineering and design controls teams
  • Executive management
  • General/corporate counsel
  • R&D staff
  • Regulatory/legislative affairs professionals
  • Study monitors
  • Study research coordinators
  • Study sponsors
  • Biobank managers
  • Biobank managing director
  • Biosample manager
  • Biorepository director

Susan G. Brink, DrPH, Exec. Vice President, e-consent Products and Services, Enforme Interactive, Inc.

Susan Brink has over 25 years of experience in research and development in the area of public health interventions, patient and consumer health information and patient decision-making. Dr. Brink has been involved in the creation of e-consent products for patients and clinical staff since 2003.  As the principal investigator on an NIH Clinical Trials Office SBIR grant to develop an electronic approach to informed consent, she provided the initial vision, guidance and research for the development of SecureConsent.